Shire PLC (LON:SHP)’s share price fell 0.7% during trading on Wednesday . The stock traded as low as GBX 3,796.50 ($51.19) and last traded at GBX 3,804.50 ($51.29). 1,382,811 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 2,569,750 shares. The stock had previously closed at GBX 3,831.50 ($51.66).

Several research firms have recently commented on SHP. Shore Capital reissued a “buy” rating on shares of Shire PLC in a report on Wednesday, June 21st. HSBC Holdings plc raised shares of Shire PLC to a “hold” rating and set a GBX 4,450 ($60.00) target price on the stock in a report on Thursday, July 6th. Royal Bank Of Canada reissued an “outperform” rating on shares of Shire PLC in a report on Friday, July 7th. J P Morgan Chase & Co reissued an “overweight” rating and issued a GBX 6,000 ($80.90) target price on shares of Shire PLC in a report on Tuesday, July 11th. Finally, Deutsche Bank AG lowered their target price on shares of Shire PLC from GBX 6,100 ($82.24) to GBX 6,000 ($80.90) and set a “buy” rating on the stock in a report on Tuesday, June 13th. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of GBX 5,837.29 ($78.70).

The stock’s market cap is GBX 34.48 billion. The firm’s 50-day moving average price is GBX 3,912.51 and its 200-day moving average price is GBX 4,376.95.

The company also recently disclosed a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be issued a GBX 3.85 ($0.05) dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a yield of 0.1%.

In related news, insider Flemming Ornskov bought 8,400 shares of the business’s stock in a transaction on Tuesday, August 22nd. The stock was acquired at an average cost of GBX 3,665 ($49.41) per share, with a total value of £307,860 ($415,073.48). Also, insider Dominic Blakemore bought 152 shares of the business’s stock in a transaction on Friday, June 30th. The stock was bought at an average cost of GBX 4,255 ($57.37) per share, with a total value of £6,467.60 ($8,719.97).

TRADEMARK VIOLATION WARNING: “Shire PLC (SHP) Shares Down 0.7%” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/20/shire-plc-shp-shares-down-0-7.html.

About Shire PLC

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.